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Hygiene hypothesis and prevalence of glomerulonephritis.
The hygiene hypothesis was proposed to explain the marked
increase in allergies that has been observed in industrialized
(Westernized) societies. This hypothesis proposes that early and
frequent exposure to bacterial and other antigens, such as is
common in developing nations, leads to a normal Th1 response,
but that better public hygiene and less infections observed in
industrialized nations may lead to persistence of the Th2 phe-
notype and thereby increase our risk for developing allergies.
Infection early in life with measles or hepatitis A virus, immu-
nization with bacille Calmette-Gue´rin, certain gastrointestinal
bacteria (lactobacillus), and environmental endotoxin exposure
may protect individuals from developing allergy in adulthood.
Paradoxically, infestation by parasites stimulates a Th2-cell re-
sponse; however, the incidence of allergic disease is very low,
perhaps due to the stimulation of T-regulatory lymphocytes that
can downregulate Th1 and Th2 responses.
Some types of human glomerulonephritis (GN) have Th1-
predominant immune responses, including crescentic and mem-
branoproliferative GN, whereas other types of GN have a
predominant Th2 immune response, including membranous
nephropathy, minimal change disease, and immunoglobulin A
nephropathy. A review of the prevalence of specific GN shows
that the higher prevalence of membranoproliferative GN in de-
veloping countries and the higher frequency of immunoglobulin
A nephropathy and minimal change disease in industrialized
countries could be explained by the hygiene hypothesis. We
suggest that studies examining Th1/Th2 balance, particularly as
it develops in childhood, should be performed to determine if
early polarization of the immune response is responsible for the
later development of specific forms of GN.
Resumen
La Hipo´tesis de la Higiene se propuso para explicar el mar-
cado incremento de alergias observado en las sociedades indus-
trializadas. La hipo´tesis propone que la exposicio´n temprana y
frecuente a bacterias y otros antı´genos, comu´n en paı´ses en
desarrollo, ocasiona una respuesta normal de Th1. Por otra
parte, una buena higiene y un menor riesgo de infeccio´n en los
paı´ses desarrollados puede inducir la persistencia del fenotipo
Th2 y en consecuencia, incrementar el riesgo de presentar aler-
gias. Las infecciones a temprana edad por el virus de la hep-
atitis A y el del sarampio´n, la inmunizacio´n con la vacuna
Bacille Calmette Guerin (BCG), la presencia de ciertas bac-
terias gastrointestinales (lactobacilos), ası´ como la exposicio´n
ambiental a ciertas endotoxinas, comunes en paı´ses en desar-
rollo, pudieran prevenir la aparicio´n de de alergias en la vida
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adulta. Parado´jicamente, la infestacio´n por para´sitos estimula
la respuesta Th2; sin embargo, la incidencia de enfermedades
ale´rgicas es baja en esta poblacio´n, debido probablemente a la
estimulacio´n de linfocitos reguladores que disminuyen las re-
spuestas tanto de Th1 y Th2.
Algunos tipos de glomerulonefritis (GN) en humanos pre-
sentan principalmente una respuesta inmune del tipo Th1, como
la GN crescentica y la membranoproliferativa (GNMP), mien-
tras que en otras, como la nefropatı´a membranosa, la de cambios
mı´nimos (GNCM) y la nefropatı´a por Iga (GNIgA) predomina
la respuesta Th2. Una revisio´n de la prevalencia de ciertos tipos
de GN, demuestra que la elevada prevalencia de GNMP en
paı´ses en desarrollo y de la GNIga y la GNCM en paı´ses industri-
alizados, pudiera explicarse en base a esta hipo´tesis. Sugerimos
el que se realicen estudios que examinen el balance Th1/Th2, es-
pecialmente durante su evolucio´n en la infancia, que permitan
determinar si la polarizacio´n temprana de la respuesta inmune
es responsable del desarrollo posterior de ciertas formas de GN.
In the last years, there has been a trend toward an in-
crease in allergic and autoimmune diseases, especially
in industrialized countries. Paradoxically, this increase
happened in association with improved public health
measures, sanitization, and quality of life. The hygiene
hypothesis was originally proposed as a mechanism to
explain the marked increase in allergies that has been
observed in industrialized (Westernized) societies [1–8].
Specifically, the hypothesis proposes that early and fre-
quent exposure to bacterial and other antigens, such as is
common in developing nations, leads to a normal Th1 re-
sponse; however, better public hygiene and less infections
observed in industrialized nations may lead to persistence
of the Th2 phenotype and thereby increase the risk for
developing allergies [9–11].
Glomerular diseases show a diverse epidemiology
throughout the world, and it has been suggested that it is
due to differences in genetics of underlying populations
or environmental exposure to putative antigens, or agents
that either trigger or induce the disease. The differences
in the prevalence of glomerular diseases, in relation to
socioeconomic status and the demonstration that some
types of glomerulonephritis (GN) have characteristic Th1
or Th2 phenotypes, suggest an association that must be
confirmed with further studies.
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MATURATION OF THE IMMUNE SYSTEM
Normally we are born with a Th2-dominant pheno-
type, which may be carried over from the mother as
a means to minimize a vigorous immune response be-
tween the mother and fetus [12]. Studies have found that
interleukin (IL)-12 production by macrophages and in-
terferon (IFN)-c production by natural killer cells are
relatively impaired in the neonate, which leads to a re-
duced Th1 response [13]. In contrast, IL-4 and IL-13 are
relatively high, consistent with a Th2-dominant response
[14]. Although the neonatal period is characterized by
a Th2 phenotype, exposure to a variety of antigens dur-
ing or after the neonatal period can convert the immune
phenotype to favor a Th1-dependent state; alternatively,
a lack of exposure to bacterial antigens, particularly dur-
ing the first 1 or 2 years of life, may favor a persistent
Th2-dependent phenotype [15]. Based on these observa-
tions, the hygiene hypothesis was developed to explain
the increasing frequency of allergies in industrialized
nations.
The process of polarization of the immune system to
either a Th1 or Th2 phenotype has been called immune
deviation and is considered to develop in early childhood.
It has been suggested that essentially adult patterns of
immunologic reactivity are established by 5 years of age
[9, 10].
CELL-MEDIATED IMMUNITY IS REGULATED
BY T-HELPER CELL SUBSETS
The immune system is largely controlled by T-helper
cells (CD4+ cells). The principal function of CD4+ cells
expressing the Th1 phenotype is the immune response
to infection. These cells are responsible for the induc-
tion of cell-mediated, organ-specific immunity and the
generation of complement-fixing antibody, and the pro-
cess is orchestrated by the release of IL-12 from acti-
vated macrophages, IFN-c from natural killer cells, and
the activation of CD4+ cells to express IL-2. CD4+ cells
expressing the Th2 phenotype are more important in the
development of allergy and the generation of im-
munoglobulin (Ig)E, IgA, and noncomplement fixing IgG
(especially subtype IgG4), and the process is mediated by
IL-4, IL-5, IL-6, IL-10, and IL-13. Th1 and Th2 counter-
regulate each other, as IFN-c inhibits the Th2 response
and IL-10 can block Th1 actions; however, both Th1 and
Th2 can also be activated simultaneously [16]. In this re-
gard, a third CD4+ cell that also expresses the IL-2a re-
ceptor (CD25) appears to have an important regulatory
role in silencing Th1 and Th2 action both via direct cell
contact and by releasing IL-10 and transforming growth
factor b [17–21].
EPIDEMIOLOGIC EVIDENCE SUPPORTING
THE HYGIENE HYPOTHESIS
Several lines of evidence have been found to support
the hygiene hypothesis. First, it is known that allergy
(which has a Th2 phenotype) is less common in situa-
tions in which exposure to infections is more common,
such as observed in situations of larger families, lower
socioeconomic status, lower birth order, and participa-
tion in day-care [2, 6]. Several studies have also reported
that infection early in life with measles or hepatitis A
virus may protect individuals from developing allergy in
adulthood [22, 23]. Immunization with bacille Calmette-
Gue´rin (BCG) can also induce a Th1 response and a
delayed hypersensitivity response to mycobacterium
antigens, and it has been reported that children who
receive BCG, particularly during the first year of life,
are also protected from allergy in adulthood provided
they maintain the delayed hypersensitivity response [24].
BCG vaccination is administered at birth in all developing
countries that have a high incidence of Mycobacterium
tuberculosis; these countries have the lowest prevalence
rates for allergic diseases. In contrast, in countries with
the highest prevalence rates for allergic disease, BCG vac-
cination is administered at school (mean age, 14–15 years)
or not at all, by which time allergic disease has already
manifested [25].
Some types of gastrointestinal bacteria have been as-
sociated with a low frequency of allergy. Children with
allergy have lower prevalence of colonization with bi-
fidobacteria and Lactobacillus. Six months of oral Lac-
tobacillus ingestion from birth halved the incidence of
atopic dermatitis; it was associated with increased serum
IL-10 but no immune deviation as measured by serum
levels of IL- 4 and IFN-c [26–30]
Environmental endotoxin exposure has also been pos-
tulated to explain the decrease incidence of atopic dis-
ease [31–34]. A recent study found that the amount of
endotoxin in mattress dust inversely correlated in a dose-
dependent way with the prevalence of hay fever and
atopic sensitization [35].
Paradoxically and in contrast to most bacterial infec-
tions, infestation by parasites stimulates a Th2-cell re-
sponse [36, 37]. Children, who are born in developing
countries where there is high exposure to parasites, de-
velop a strong Th2 response, with high levels of IL-4, IL-5,
and IL-13, and although they often have a positive skin
prick test to various antigens, the incidence of allergic
disease is very low. The explanation for this paradoxical
phenomena might be that parasites, besides inducing a
strong Th2 response, also stimulate T-regulatory lympho-
cytes which increase the secretion of IL-10 and TGF-b ,
both which can downregulate Th1 and Th2 responses [38,
39].
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T-HELPER CELL SUBSETS IN
GLOMERULONEPHRITIS
Studies largely led by Holdsworth and Tipping [40–48],
have demonstrated that some types of human GN have
Th1-predominant immune responses, including crescen-
tic, antiglomerular basement membrane, and membra-
noproliferative GN (MPGN). Other types of GN have
predominant Th2 immune response, including membra-
nous nephropathy, minimal change disease, and IgA
nephropathy.
Minimal change disease (MCD) may be an example
of a Th2-dependent glomerular disease. It is frequently
associated with atopy [49–52], elevated IgE levels [53–
57], elevated levels of IL-4 in peripheral T cells [58–61],
and increased production of IL-13 during relapse. IL-13
regulates the switching of Ig production toward IgE [62].
T lymphocytes from patients with MCD display a down-
regulation of the IL-12 receptor b2 subunit (IL-12R b2)
during relapse. The IL-12R b2 is selectively expressed by
Th1 cells and plays a key role in the transduction of IL-12
signaling through the JAK/STAT pathway [63, 64].
IgA nephropathy is a glomerular disease that is likely
Th2 dependent. Although occasional studies find evi-
dence for some Th1 activation in IgA nephropathy [65,
66], the majority of studies has found that the principal
cytokines produced by circulating T cells are IL-4, IL-5,
IL-6, IL-10, and IL-13, which are all Th2-dependent cy-
tokines [67–70]. IgA production is driven by IL-5, a Th2
cytokine [71]. There is also evidence that Th2 cytokines
can also alter glycosylation of IgA [72], which is known to
be a key factor in its pathogenesis [73]. Furthermore, ex-
perimental IgA nephropathy is much more severe and is
associated with more abnormalities in IgA glycosylation
in mice that have a predominant Th2 response (BALB/c)
compared with control (C3HeB) mice [74]. Some patients
with IgA nephropathy also manifest atopy [75, 76] and el-
evated IgE levels [77], and others develop IgA antibodies
to food antigens [78].
There are few studies that have examined the Th
phenotype in MPGN [41]. However, an increase in
granulocyte-macrophage colony-stimulating factor [79]
and predominant deposition of IgG3 in the glomeruli
[80] have been found in MPGN, thereby suggesting a
Th1 phenotype pattern. The chronic use of granulocyte-
macrophage colony-stimulating factor in a neutropenic
patient has also led to the development of MPGN [81].
THE EPIDEMIOLOGIC PATTERNS OF
GLOMERULAR DISEASE OBSERVED
IN THE WORLD
The prevalence of biopsy-proven glomerulonephritis
varies according to different conditions, including the
race and age of the patient, geographic area, and local
indications for renal biopsy. However, a true variation
Table 1. Epidemiology of primary GN and socieconomic status
IgA MCD MPGN GNP
Countries % % % US$
Nigeria (N = 41) − 9 51 770
Peru (N = 1263) 1 5 23 4480
Paraguay (N = 678) 3 1 25 4380
South Africa (N = 104) 5 1 22 8710
Japan (N = 1850) 30 26 7 25,170
Spain (N = 7016) 17 19 4.3 17,850
France (N = 1990) 36 10.7 2.3 23,020
Italy (N = 13,835) 37 7 6.3 22,000
Australia (N = 2030) 34 4.4 2.2 23,850
United States (N = 2000) 9 15 2 31,910
Abbreviations are: GN, glomerulonephritis; IgA, immnuoglobulin A; MCD,
minimal change disease; MPGN, membranoproliferative GN; GNP, gross
national product.
Data taken from [83–88, 90, 91].
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Fig. 1. Changes in the prevalence of MPGN. Adapted from [83, 84, 88,
90].
may exist between populations around the world, the
causes of which are unknown but which have been previ-
ously suggested to be due to differences in environment,
socioeconomic status, and presence of infections. These
explanations bear striking similarity to the hygiene hy-
pothesis, which leads us to assume that in developing
countries the types of GN observed would predominantly
reflect a Th1 phenotype, whereas in industrialized nations
GN associated with a Th2 phenotype would predominate
[82].
A review of the prevalence of specific GN with dom-
inant Th2 response (MCD and IgA nephropathy) and
dominant Th1 response (MPGN) in different countries
in the world [83–91] shows that MPGN is the most com-
mon GN in developing countries, whereas IgA nephropa-
thy and MCD are most common in industrialized nations
(Table 1). MPGN has also remained the main cause of
primary GN in Peru in recent years, whereas in Spain,
Italy, and the United States this type of GN (Fig. 1) has
decreased, consistent with the improvement in the econ-
omy of these latter nations.
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In conclusion, the state of immune balance may be a
critical factor for predisposing an individual to GN. In
developing countries, overstimulation of the immune sys-
tem with numerous infections may lead to a Th1 pre-
dominance and susceptibility to MPGN and proliferative
types of GN; in contrast, in Westernized nations fewer
exposures to infections may lead to a Th2-dominant phe-
notype and an increased risk for IgA nephropathy and
MCD. The hygiene hypothesis suggests that this immune
balance may be set early in life, perhaps within the first
5 years of age. The hypothesis also suggests that it is not
the antigen that is critical for the development of GN but
rather the immune response. Prior hypotheses that ex-
plain the increased prevalence of MPGN focused on the
increased risk of infections, with the concept that certain
infections might lead to such a strong immune response
that MPGN would result. However, in a study of MPGN
in Peru, we were not able to demonstrate any clinical
evidence for infection in the vast majority of patients pre-
senting with MPGN, which suggests that the antigen was
likely relatively innocuous but that the immune response
was aberrant [88]. Hence, we suggest that studies exam-
ining the Th1/Th2 balance, particularly as it develops in
childhood, be performed to determine if early polariza-
tion of the immune response is responsible for the later
development of specific forms of GN.
Reprint requests to Richard J. Johnson, M.D., Division of Nephrology,
Hypertension and Transplantation, University of Florida, Gainesville,
FL.
E-mail: johnsrj@medicine.ufl.edu
REFERENCES
1. LEIBOWITZ U, ANTONOVSKY A, MEDALIE JM, et al: Epidemiological
study of multiple sclerosis in Israel. II. Multiple sclerosis and level
of sanitation. J Neurol Neurosurg Psychiatry 29:60–68, 1966
2. STRACHAN DP: Hay fever, hygiene, and household size. BMJ
299:1259–1260, 1989
3. MATRICARDI PM, RONCHETTI R: Are infections protecting from
atopy? Curr Opin Allergy Clin Immunol 1:413–419, 2001
4. JONES PD, GIBSON PG, HENRY RL: The prevalence of asthma ap-
pears to be inversely related to the incidence of typhoid and tuber-
culosis: Hypothesis to explain the variation in asthma prevalence
around the world. Med Hypotheses 55:40–42, 2000
5. HOLT PG, MACAUBAS C, PRESCOTT SL, SLY PD: Microbial stim-
ulation as an etiologic factor in atopic disease. Allergy 54:12–16,
1999
6. VON HERTZEN LC: Puzzling association between childhood infec-
tions and the later occurrence of asthma and atopy. Ann Med
32:397–400, 2000
7. MAZIAK W: The hygiene hypothesis and the evolutionary perspec-
tive of health. Prev Med 35:415–418, 2002
8. BACH JF: The effect of infections on susceptibility to autoimmune
and allergic diseases. N Engl J Med 347:911–920, 2002
9. HOLT PG, O’KEEFFE P, HOLT BJ, et al: T–cell ‘priming’ against
environmental allergens in human neonates: Sequential deletion
of food antigen reactivity during infancy with concomitant expan-
sion of response to ubiquitous inhalant allergens. Pediatr Allergy
Immunol 6:85–90, 1995
10. YABUHARA A, MACAUBAS C, PRESCOTT SL, et al: TH2-polarized im-
munological memory to inhalant allergens in atopics is established
during infancy and early childhood. Clin Exp Allergy 27:1261–1269,
1997
11. PRESCOTT SL, MACAUBAS C, HOLT BJ, et al: Transplacental priming
of the human immune system to environmental allergens: Uni-
versal skewing of initial T cell responses toward the Th2 cytokine
profile. J Immunol 160:4730–4737; 1998
12. WEGMANN TG, LIN H, GUILBERT L, MOSMANN TR: Bi-directional
cytokine interactions in the maternal-fetal relationship: Is success-
ful pregnancy a Th2 phenomenon? Immunol Today 14:353–356,
1993
13. JONES CA, WARNER JO: Regulating a regulator: IFNc production
by the neonate. Clin Exp Allergy 29:865–868, 1999
14. INOUE Y, KONIECZNY BT, WAGENER ME, et al: Failure to in-
duce neonatal tolerance in mice that lack both Il-4 and IL-13
but not in those that lack IL-4 alone. J Immunol 167:1125–1128,
2001
15. FORSTHUBER T, YIP HC, LEHMANN PV: Induction of Th1 and Th2
immunity in neonatal mice. Science 271:1728–1730, 1996
16. SIMPSON CR, ANDERSON WJA, HELMS PJ, et al: Coincidence of
immune-mediated diseases driven by Th1 and Th2 subsets suggests
a common etiology. A population based study using computerized
general practice data. Clin Exp All 32:37–42, 2002
17. SAKAGUCHI S, SAKAGUCHI N, ASANO M, et al: Immunological self-
tolerance maintained by activated T cells expression IL-2 receptor
a-chains (CD25). J Immunol 155:1151–1164, 1995
18. ANNUNZIATO F, COSMI L, LIOTTA F, et al: Phenotype, localization,
and mechanism of suppression of CD4+CD25+ human thymo-
cytes. J Exp Med 196:379–387, 2002
19. NG WF, DUGGAN PJ, PONCHEI F, et al: Human CD4+CD25+ cells:
A naturally occurring population of regulatory T cells. Blood
98:2736–2744, 2001
20. DE LAFAILLE MAC, LAFAILLE JJ: CD4+ regulatory T cells in au-
toimmunity and allergy. Curr Opin Immunol 14: 771–778, 2002
21. KOHM AP, CARPENTER PA, ANGER HA, MILLER SD: Cutting edge:
CD4+CD25+ regulatory T cells suppress antigen-specific autore-
active immune responses and central nervous system inflammation
during active experimental autoimmune encephalomyelitis. J Im-
munol 169:4712–4716, 2002
22. SHAHEEN SO, AABY P, HALL AJ, et al: Measles and atopy in Guinea-
Bissau. Lancet 347:1792–1796, 1996
23. MATRICARDI PM, ROSMINI F, FERRIGNO L, et al: Cross sectional
retrospective study of prevalence of atopy among Italian military
students with antibodies against hepatitis A. BMJ 314:999–1003,
1997
24. SHIRIKAWA T, ENOMOTO T, SHIMAZU S, HOPKIN JM: The inverse
association between tuberculin responses and atopic disorder. Sci-
ence 275:77–79, 1997
25. KRISHMA MT, SALVI SS: Could administration of bacilli Calmette-
Gue´rin vaccination at birth protect from the development of
asthma and allergic diseases in the western world? Has this ques-
tion been adequate investigated? Pediatr Allergy Immunol 13:172–
176, 2002
26. KALIOMAKI M, SALIMEN S, ARVILOMMI H, et al: Probiotics in primary
prevention of atopic disease: A randomized placebo-controlled
trial. Lancet 357:1076–1079, 2001
27. BJORKSTEN B, NAABER P, SEEP E, MIKELSAAR M: The intestinal
microflora in allergic Estonian and Swedish 2 year-old children.
Clin Exp Allergy 29:342–346, 1999
28. KALIOMAKI M, KIRJAVAINEN P, EEROLA E, et al: Distinct patterns
of neonatal gut microflora in infants developing or not developing
atopy. J Allergy Clin Immunol 107:129–134, 2001
29. BJORKSTEN B, SEEP E, JULGE K, et al: The intestinal microflora dur-
ing the first two years of life and allergy development. J Allergy
Clin Immunol 108:516–520, 2001
30. PESSI T, SUTAS Y, HURME M, ISOLAURI E: Interleukin-10 generation
in atopic children following oral Lactobacillus rhamonosus GG.
Clin Exp Allergy 30:1804–1808, 2000
31. VON MUTIUS E, BRAUN-FAHRLANDER C, SCHIERL R, et al: Expo-
sure to endotoxin or other bacterial components might protect
against the development of atopy. Clin Exp Allergy 30:1230–1234,
2000
32. GEREDA JE, LEUNG DY, THATAYATIKOM A, et al: Relation between
house-dust exposure, type 1 T-cell development, and allergen sen-
sitization in infants with high risk of asthma. Lancet 355:1680–1683,
2000
S-66 Hurtado and Johnson: Hygiene hypothesis and glomerulonephritis
33. DOUWES J, ZUIDHOF A, DOEKES G, et al: (1→ 3)-beta-D-glucan and
endotoxin in house dust and peak flow variability in children. Am
J Respir Crit Care Med 162:1348–1354, 2000
34. LAUW FN, TEN HOVE T, DEKKERS PE, et al: Reduced Th1, but not
Th2, cytokine production by lymphocytes after in vivo exposure
of healthy subjects to endotoxin. Infect Immunol 68:1014–1018,
2000
35. BRAUN-FAHRLANDER C, RIEDLER J, HERZ U, et al: Environmental
exposure to endotoxin and its relation to asthma in school-age
children. N Engl J Med 347:869–877, 2002
36. FINKELMAN FD, URBAN JF Jr: The other side of the coin: the protec-
tive role of the Th2 cytokines. J Allergy Clin Immunol 107:772–780,
2001
37. WEINSTOCK J, SUMMERS R, ELLIOT D, et al: The possible link between
de-worming and the emergence of immunological disease. J Lab
Clin Med 139:334–338, 2002
38. YAZDANBAKHSH M, VAN DEN BIGGELAAR A, MAIZELS R: Th2 re-
sponses with atopy: Immunoregulation in chronic helmint infec-
tions and reduced allergic disease. Trend Immunol 22:372–377,
2001
39. YAZDANBAKHSH M, KREMSNER P, VAN REE R: Allergy, parasites, and
the hygiene hypothesis. Science 296:490–494, 2002
40. TIPPING PG, KITCHING AR, HUANG XR, et al: Immune modulation
with interleukin-4 and interleukin-10 prevents crescent formation
and glomerular injury in experimental glomerulonephritis. Eur J
Immunol 27:530–537, 1997
41. HOLDSWORTH SR, KITCHING AR, TIPPING PG: Th1 and Th2 T helper
subsets affect patterns of injury and outcomes in glomerulonephri-
tis. Kidney Int 55:1198–1216, 1999
42. KITCHING AR, HOLDSWORTH SR, TIPPING PG: IFN-c mediates
crescent formation and cell-mediated immune injury in murine
glomerulonephritis. J Am Soc Nephrol 10:752–759, 1999
43. KITCHING AR, HOLDSWORTH SR, TIPPING PG: Crescentic glomeru-
lonephritis a manifestation of a nephritogenic Th1 response? Histol
Histopathol 15:993–1003, 2000
44. KITCHING AR, TIPPING PG, KURIMOTO M, HOLDSWORTH SR: IL-
18 has IL-12 independent effects in delayed-type hypersensitivy:
Studies in cell-mediated crescientic glomerulonephritis. J Immunol
165:4649–4657, 2000
45. HUANG XR, KITCHING AR, TIPPING PG, HOLDSWORTH SR:
Interleukin-10 inhibits macrophage-induced glomerular injury. J
Am Soc Nephrol 11:262–269, 2000
46. TIMOSHANCO JR, KITCHING AR, HOLDSWORTH SR, TIPPING PG:
Interleukin-12 from intrinsic cells is an effector of renal injury
in crescient glomerulonephritis. J Am Soc Nephrol 12:464–471,
2001
47. KITCHING AR, HUANG XR, TURNER AL, et al: The requirement for
GM-CSF in leukocyte mediated immune glomerular injury. J Am
Soc Nephrol 13:350–358, 2002
48. KITCHING AR: Cytokines, T cells and proliferative glomeru-
lonephritis. Nephrology 7:244–249, 2002
49. LAGRUE G, LAURENT J: Allergy and lipoid nephrosis. Adv Nephrol
12:151–175, 1983
50. REEVES WG, CAMERON JS, JOHANSSON SGO, et al: Seasonal
nephrotic syndrome: description and immunological findings. Clin
Allergy 5:121–137, 1975
51. HARDWICKE J, SOOTHILL JF, SQUIRE JR, HOLT JG: Nephrotic syn-
drome with pollen hypersensitivity. Lancet 1:500, 1959
52. RYTNAD DA: Onset of the nephrotic syndrome during a reaction
to bee sting. Stanford Med Bull 13:224–233, 1995
53. SCHULTE-WISSERMAN H, GO¨RTZ W, STRAUB E: IgE in patients with
glomerulonephritis and minimal change nephrotic syndrome. Eur
J Pediatr 131:105–111, 1979
54. CHAN MK, CHAN KW, JONES B: Immunoglobulins (IgG, IgA, IgM,
IgE) and complement components (C3, C4) in nephrotic syndrome
due to minimal change and other forms of glomerulonephritis, a
clue for steroid therapy? Nephron 47:125–130, 1987
55. SHU KH, LIAN JD, YANG YF, et al: Serum IgE in primary glomerular
diseases and its clinical significance. Nephron 49:24–28, 1988
56. REEVES WG, CAMERON JS, OGG CS: IgE and the nephrotic syn-
drome. Lancet I:1299–1300, 1971
57. YOKOYAMA H, KIDA H, TANI Y, et al: Immunodynamics of minimal
change nephrotic syndrome in adults T and B lymphocyte subsets
and serum immunoglobulin levels. Clin Exp Immunol 61:601–607,
1985
58. KANG J, BAI KM, WANG BL, et al: Increased production of inter-
leukin 4 in children with simple idiopathic nephrotic syndrome.
Chin Med J (Engl) 107:347–350, 1994
59. CHO BS, YOON SR, JANG JY, et al: Upregulation of interleukin-4
and CD23/FcξRII in minimal change nephrotic syndrome. Pediatr
Nephrol 13:199–204, 1999
60. LAMA G, LUONG I, TIRINO G, et al: T-lymphocyte populations and
cytokines in childhood nephrotic syndrome. Am J Kidney Dis
39:958–965, 2002
61. GONG WK, CHEUNG W, YAP HK: Minimal change nephrotic
syndrome—A complex genetic disorder. Ann Acad Med Singa-
pore 29:351–356, 2000
62. TENBROCK K, SCHUBERT A, STAPENHORST L, et al: Type I IgE re-
ceptor, interleukin 4 receptor and interleukin 13 polymorphism in
children with nephrotic syndrome. Clin Sci (Lond) 102:507–512,
2002
63. SAHALI D, PAWLAK A, VALANCIUTE A, et al: A novel approach to in-
vestigation of the pathogenesis of active minimal-change nephritic
syndrome using subtracted cDNA library screening. J Am Soc
Nephrol 13:1238–1247, 2002
64. GRIMBERT P: Recent approach to the pathogenesis of minimal
change nephritic syndrome. Nephrol Dial Transplant 18:245–248,
2003
65. LAI KN, HO TH, LAI CKW, et al: Increase of both Th1 and Th2
T lymphocyte subsets in IgA nephropathy. Clin Exp Immunol
96:116–121, 1994
66. LIM CS, ZHENG SM, KIM YS, et al: Th1/Th2 predominance
and proinflammatory cytokines determine the clinicopathological
severity of IgA nephropathy. Nephrol Dial Transplant 16:269–275,
2001
67. LAI KN, HO TH, LAI CKW, et al: Increase of both Th1 and Th2
T lymphocyte subsets in IgA nephropathy. Clin Exp Immunol
96:116–121, 1994
68. LIM CS, ZHENG SM, KIM YS, et al: Th1/Th2 predominance
and proinflammatory cytokines determine the clinicopathological
severity of IgA nephropathy. Nephrol Dial Transplant 16:269–275,
2001
69. ICHINOSE H, MIYAZAKI M, KOJI T, et al: Detection of cytokine
mRNA-expressing cells in peripheral blood of patients with IgA
nephropathy using non-radioactive in situ hybridization. Clin Exp
Immunol 103:125–132, 1996
70. EBIHARA I, HIRAYAMA K, YAMAMOTO S, et al: Th2 predominance
at the single cell level in patients with IgA nephropathy. Nephrol
Dial Transplant 16:1783–1789, 2001
71. SONODA E, HITOSHI Y, YAMAGUCHI N, et al: Differential regulation
of IgA production by TGF-b and IL-5; TGF-b induces surface IgA-
positive cells bearing IL-5 receptor, whereas Il-5 promotes their
survival and maturation into IgA-secreting cells. Cell Immunol
140:158–172, 1992
72. CHINATALACHARUVU SR, EMANCIPATOR SN: The glycosylation of
IgA produced by murine B cells is altered by Th2 cytokines. J
Immunol 159:2327–2333, 1997
73. MESTECKY M, TOMANA M, CROWLEY-NOWICK Z, et al: Defec-
tive galactosylation and clearance of IgA1 molecules as a possi-
ble etiopathogenic factor in IgA nephropathy. Contrib Nephrol
104:172–178, 1993
74. CHINTALACHARUVU SR, NAGY NU, SIGMUND JG, et al: T cell cy-
tokines determine the severity of experimental IgA nephropathy
by regulating IgA glycosylation. Clin Exp Immunol 126:326–333,
2001
75. ENDOH M, TOMINO Y, NOMOTO Y, et al: Clinical symptoms and
laboratory findings in patients with IgA nephropathy (in Japanese)
Jpn J Nephrol 23:1201–1208, 1981
76. CARAMAN PL, AZOULAY E, KESSLER M, et al: Mucosal infec-
tions and allergy in IgA nephropathy. Contrib Nephrol 104:24–30,
1993
77. YANO N, MIYAZAKI M, ENDOH M, et al: Increase of CD23-positive
cells in peripheral blood from patients with IgA nephropathy and
non-IgA proliferative glomerulonephritis. Nephron 60:404–410,
1992
78. ROSTOKER G, LAURENT J, ANDRE C, et al: High levels of
Hurtado and Johnson: Hygiene hypothesis and glomerulonephritis S-67
IgA antigliadin antibodies in patients who have IgA mesangial
glomerulonephritis but not celiac disease. Lancet 1:356–357, 1988
79. KITCHING AR, RU HUANG X, TURNER AL, et al: The requirement
for granulocyte-macrophage colony-stimulating factor and gran-
ulocyte colony-stimulating factor in leukocyte-mediated immune
glomerular injury. J Am Soc Nephrol 13:350–358, 2002
80. IMAI H, HAMAI K, KOMATSUDA A, et al: IgG subclasses in pa-
tients with membranoprliferative glomerulonephritis, membra-
nous nephropathy and lupus nephritis. Kidney Int 51:270–276, 1993
81. MAGEN D, MANDEL H, BERANT M, et al: MPGN type I induced by
granulocyte colony stimulating factor. Pediatr Nephrol 17:370–372,
2002
82. JOHNSON RJ, HURTADO A, MERSZEI J, et al: Hypothesis: Dysreg-
ulation of immunologic balance resulting from hygiene and so-
cioeconomic factors may influence the epidemiology and causes
of glomerulonephritis worldwide. Am J Kidney Dis 43:575–581,
2003
83. SIMON P, RAMEE M, AUTULY M, et al: Epidemiology of primary
glomerular diseases in a French region. Variations according to
period and age. Kidney Int 46:1192–1198, 1994
84. HAAS M, MEEHAN SM, KARRISON TG, SPARGO BH: Changing eti-
ologies of unexplained adult nephrotic syndrome: A comparison of
renal biopsy findings from 1976–1979 and 1995–1997. Am J Kidney
Dis 30:621–631, 1997
85. SCHENA P: Survey of the Italian Registry of Renal Biopsies. Fre-
quency of the renal diseases for 7 consecutive years. Nephrol Dial
Transplant 12:418–426, 1997
86. ASINOBI AO, GHADEGESIN RA, ADEYAMO AA, et al: The predomi-
nance of membranoproliferative glomerulonephritis in childhood
nephritic syndrome in Ibadan, Nigeria. West Afr J Med 18:203–205,
1999
87. RESEARCH GROUP ON PROGRESISIVE CHRONIC RENAL DISEASE: Na-
tionwide and long-term survey of primary glomerulonephritis in
Japan as observed in 1,850 biopsied cases. Nephron 82:205–213,
1999
88. HURTADO A, ESCUDERO E, STROMQUIST C, et al: Distinct patterns
of glomerular disease in Lima, Peru. Clin Nephrol 53:325–332,
2000
89. BRIGANTI E, DOWLING J, FINLAY M, et al: The incidence of biopsy-
proven glomerulonephritis in Australia. Nephrol Dial Transplant
16:1364–1367, 2001
90. RIVERA F, LO´PEZ-GO´MEZ JM, PE´REZ-GARCı´A R: Frequency of renal
pathology in Spain 1994–1999. Nephrol Dial Transplant 17:1594–
1602, 2002
91. MADALA ND, NAICKER S, SINGH B, et al: The pathogenesis of mem-
branoproliferative glomerulonephritis in KwaZulu-Natal, South
Africa is unrelated to hepatitis C virus infection. Clin Nephrol
60:69–73, 2003
